-+ 0.00%
-+ 0.00%
-+ 0.00%

Citius Pharma prices USD 5 million registered direct offering at USD 0.99/share

PUBT·04/24/2026 12:02:09
Listen to the news
Citius Pharma prices USD 5 million registered direct offering at USD 0.99/share
  • Citius Pharmaceuticals launched a registered direct offering targeting gross proceeds of about USD 5 million.
  • Deal covers 5,076,143 common shares or pre-funded warrants at USD 0.99 per share.
  • Concurrent private placement includes unregistered warrants for up to 5,076,143 shares at USD 0.86 per share.
  • Warrants become exercisable immediately upon issuance, expiring five years after effectiveness of a registration statement for resale shares.
  • Net proceeds earmarked for LYMPHIR commercial launch support, product development, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE42764) on April 24, 2026, and is solely responsible for the information contained therein.